This Trauma session was recorded live at the 2025 AANS Annual Scientific Meeting.
This session explores the challenges and outcomes faced by patients with traumatic spinal injuries after discharge, with a focus on post-care management, rehabilitation and strategies for improving long-term outcomes. The session features the Tator Lecture, which examines this critical topic and its implications for advancing care and improving patient outcomes. Additionally, the session will showcase the Natus Award-Winning Abstracts, recognizing groundbreaking research.
Speakers: Paul Arnold, Michael Fehlings, Ramesh Grandhi, Zhigang He, S. Hoffer, Anna Huguenard, Chibuikem Ikwuegbuenyi, Yi Lu, Mark MacLean, Laura Ngwenya, Martina Stippler, Suzanne Tharin
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The last date to claim credit is 06/26/2027.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Those who have disclosed a relationship with ineligible companies are listed below.
All disclosed financial relationships have been mitigated in accordance with ACCME standards.
Name
|
Relationship/Company |
Ramesh Grandhi |
Balt: Consultant (Ongoing), Research Grant (Ongoing); Cerenovus: Consultant (Ongoing), Research Grant (Ongoing); Integra Life Sciences: Research Grant (Ongoing); Medtronic Inc: Consultant (Ongoing), Research Grant (Ongoing); Rapid Medical: Consultant (Ongoing); Stryker Neurovascular: Consultant (Ongoing) |
Zhigang He |
Axonis: Advisor (Ongoing); Dompe: Research Grant (Ongoing), Speaker/Honoraria (Ongoing); Myrobalan: Stock Shareholder (excluding mutual funds) (Ongoing); Rugen: Stock Shareholder (excluding mutual funds) (Ongoing) |
Anna Huguenard |
Aurenar: Board Member/Officer/Trustee (Ongoing), Ownership or Partnership (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing) |
Laura Ngwenya |
Abbott: Grant/Research Support (Ongoing); Biogen: Grant/Research Support (Ongoing) |
Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.